In 2023, Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer patient. The patient had to choose between an established therapy with a high likelihood of unwanted side effects or a newer experimental treatment.
Leave A Comment